A Digital Hub of New Approach Methdologies-based (NAM) solutions for the drugs and cosmetics product development industries
Addressing the shifting needs of Drugs & Cosmetics product development industries
| R&D | Screen and optimize early-stage compounds using NAMs |
| Pre-Clinical Testing | De-risk candidates by predicting human responses before in vivo studies |
| Safety Norms | Assess product safety using validated NAMs |
| Toxicity Testing | Identify toxic effects and mechanisms through NAMs |
Covering scientifically-recognized Alternatives to Animal testing solution providers
| In Vitro Models | Cells, tissues, ex-vivo samples for lab testing |
| Microphysiological Systems (MPS) | Organoids & organ-on-chip mimicking organ physiology |
| In Chemico Assays | Chemical reactivity tests without cells or animals |
| High-Throughput / High-Content Screening | Automated cell/tissue assays for rapid testing |
| Omics Platforms | Molecular profiling (transcriptomics, proteomics, metabolomics) |
| In Silico Tools | Computational toxicity & drug discovery (QSAR, AI/ML, PBPK, read-across). |
| Human Data–Based Solutions | Clinical microdosing, biomonitoring, and epidemiology-based insights |

Discover the Latest Range of Industry-Ready Alternatives to Animal Testing Solutions
R&D | Pre-Clinial Testing | Product Safety | Toxicity testing